Novartis AG (SWX:NOVN) is seeking M&A. Vasant Narasimhan, Chief Executive Officer said, "when you look at that balance sheet that the company currently has, we have a lot of flexibility. You can see on the left-hand side of this chart, we are well positioned versus the peer set in terms of our overall rating. And then similarly, when you look at our leverage, very nicely -- a nice balance sheet that gives us a lot of flexibility either to pursue attractive M&A or to continue to return capital to our shareholders".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
93.07 CHF | +0.81% | +5.64% | +9.66% |
13/05 | Legend Biotech 1Q Loss Narrows with Higher Carvykti Sales | DJ |
10/05 | Novartis’ Scemblix Gets Third US FDA Breakthrough Therapy Designation | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+9.66% | 208B | |
+29.98% | 684B | |
+30.34% | 568B | |
-3.52% | 361B | |
+18.59% | 329B | |
+4.07% | 284B | |
+16.21% | 240B | |
-6.83% | 200B | |
+7.09% | 166B | |
-1.22% | 159B |
- Stock Market
- Equities
- NOVN Stock
- News Novartis AG
- Novartis Seeks M&A